APOLLO‐2: A Randomized, Placebo and Active‐Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein–Biased Ligand at the μ‐Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty

OBJECTIVES: The clinical utility of conventional IV opioids is limited by the occurrence of opioid‐related adverse events. Oliceridine is a novel G protein–biased μ‐opioid receptor agonist designed to provide analgesia with an improved safety and tolerability profile. This phase III, double‐blind, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Singla, Neil K., Skobieranda, Franck, Soergel, David G., Salamea, Monica, Burt, David A., Demitrack, Mark A., Viscusi, Eugene R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851842/
https://www.ncbi.nlm.nih.gov/pubmed/31162798
http://dx.doi.org/10.1111/papr.12801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851842/
https://www.ncbi.nlm.nih.gov/pubmed/31162798
http://dx.doi.org/10.1111/papr.12801

Ejemplares similares